Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score

Podobne zapisy

• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
  od: Onozawa, Mizuki, i wsp.
  Wydane: (2018)
• Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
  od: Cooperberg, Matthew R., i wsp.
  Wydane: (2009)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  od: Satoru Ueno, i wsp.
  Wydane: (2018-03-01)
• Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
  od: Ueno, Satoru, i wsp.
  Wydane: (2018)
• Modified J‐CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy
  od: Lim, Jasmine, i wsp.
  Wydane: (2020)